Recently, it has been demonstrated that it is a specific marker expressed on LSCs of CML, both in BM and PB samples, and absent on CD34+/CD38− stem cells in normal subjects or on LSCs of other myeloid neoplasms. Here, CD38 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.